ERBB3 and lung adenocarcinoma: In a gene expression study of 10 ‘signature’ genes in early lung adenocarcinoma, a two-gene signature, comprising only ERBB3 and BRCA1 expression was an independent risk factor in predicting survival, improving the discriminatory power of conventional classification systems (41).